Black Diamond Therapeutics (BDTX) Capital Expenditures (2019 - 2026)
Black Diamond Therapeutics (BDTX) posted Capital Expenditures of -$44000.0 for Q1 2026, little changed on a QoQ basis from -$44000.0 in Q4 2025, and little changed year-over-year from -$44000.0 in Q1 2025.
Black Diamond Therapeutics (BDTX) Capital Expenditures (2019 - 2026) Analysis & Trends
Black Diamond Therapeutics' Capital Expenditures history runs 8 years deep, the most recent figure standing at -$44000.0 for Q1 2026.
- Quarterly Capital Expenditures changed 0.0% year-over-year to -$44000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$176000.0 (down 185.85% YoY) and the FY2025 annual result came in at -$176000.0, down 170.68% from the prior year.
- Capital Expenditures was -$44000.0 for Q1 2026 at Black Diamond Therapeutics, roughly flat from -$44000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $337000.0 in Q2 2024 and bottomed at -$44000.0 in Q3 2024.
- A 5-year average of $21166.7 and a median of -$44000.0 in 2024 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures surged 121.45% — and 2024, when it plunged 233.33%.
- Black Diamond Therapeutics' Capital Expenditures stood at $192000.0 in 2022, then sank by 82.81% to $33000.0 in 2023, then plunged by 233.33% to -$44000.0 in 2024, then changed by 0.0% to -$44000.0 in 2025, then changed by 0.0% to -$44000.0 in 2026.
- Business Quant data shows BDTX's Capital Expenditures at -$44000.0 in Q1 2026, -$44000.0 in Q4 2025, and -$44000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 43.25 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 786,000.00 |
| 10 | Black Diamond Therapeutics | 99.59 Mn | -18.67 Mn | - | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44,000.00 |
| Mar 31, 2026 | -44,000.00 |
| Dec 31, 2025 | -44,000.00 |
| Dec 31, 2025 | -44,000.00 |
| Sep 30, 2025 | -44,000.00 |
| Sep 30, 2025 | -44,000.00 |
| Jun 30, 2025 | -44,000.00 |
| Jun 30, 2025 | -44,000.00 |
| Mar 31, 2025 | -44,000.00 |
| Mar 31, 2025 | -44,000.00 |
| Dec 31, 2024 | -44,000.00 |
| Dec 31, 2024 | -44,000.00 |
| Sep 30, 2024 | -44,000.00 |
| Sep 30, 2024 | -44,000.00 |
| Jun 30, 2024 | 337,000.00 |
| Jun 30, 2024 | 337,000.00 |
| Dec 31, 2023 | 33,000.00 |
| Dec 31, 2023 | 33,000.00 |
| Sep 30, 2022 | 192,000.00 |
| Sep 30, 2022 | 192,000.00 |